TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

LATEST NEWS

Merck Faces Hep C Pricing Dilemma to Counter Gilead, Abbvie
OPINION

The Street Can't Help but Love Amgen

Merck Faces Hep C Pricing Dilemma to Counter Gilead, Abbvie
STOCKS

Biotech Stock Bubble Talk Deflated By Cost-Conscious Buyers

Today's Weak On High Volume Stock: Ocean Rig UDW (ORIG)
MARKETS

Trade-Ideas: Onyx Pharmaceuticals (ONXX) Is Today's "Water-Logged And Getting Wetter" Stock

Jim Cramer's 'Mad Money' Recap: The Market's Wild Ride
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan

Genfit Digs Even Deeper to Find Hidden Benefit in Fatty Liver Drug
STOCKS

Grading the Twitterverse's 2013 Biotech Stock Picks

Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan
JIM CRAMER

Cramer's 'Mad Money' Recap: More Selling to Come

Jim Cramer's 'Mad Money' Recap: My Game Plan for Next Week
JIM CRAMER

Cramer's 'Mad Money' Recap: A Market Too Good to Ignore

3 Basic Materials Stocks Driving The Sector Higher
MARKETS

Onyx Pharmaceuticals Inc. (ONXX): Today's Featured Drugs Winner

Capital One, Discover Are Bargains as Industry Resumes Growth
INVESTING

Visa, MasterCard: Dog-Day Financial Losers

Here's One Trick Investors Can Use This Earnings Season
MARKETS

Stocks Drop as U.S. Challenges Syria's Chemical Attack

Stock Market Today - Greece Weighs on the Markets
OPINION

[video] Quick Take: Cramer on Mergers and Markets

BAE Systems Appoints Advisers to Review U.S. Operations
MERGERS AND ACQUISITIONS

The Deal: Amgen Soars on $10.4B Onyx Deal

Genfit Digs Even Deeper to Find Hidden Benefit in Fatty Liver Drug
STOCKS

Amgen Regains Biotech Growth Cred With $10B Onyx Acquisition

Cramer on Mergers and Markets
VIDEO

Cramer on Mergers and Markets

Fundamentally Strong Stocks Will Prevail in a Correction
MARKETS

Stock Futures Weak While Onyx Surges

Mergers Don't Lift Stocks
VIDEO

Mergers Don't Lift Stocks

Jones Lang LaSalle (JLL) Reaches New Lifetime High Today
MARKETS

Trade-Ideas: Onyx Pharmaceuticals (ONXX) Is Today's Pre-Market Mover With Heavy Volume Stock

Stocks Fluctuate as Oil Pares Losses, Greek Talks Continue
STOCKS

Morning Briefing: 10 Things You Should Know

Looking at Mannkind's Afrezza Sales Estimates Ahead of Sanofi Earnings
STOCKS

Onyx Pharma CEO Turns $1 Billion Into $10 Billion With Amgen Takeout

Uncertainty Remaining in Boston Scientific
MERGERS AND ACQUISITIONS

Amgen and Onyx Pharmaceuticals Reported to be Near Deal

Market Hustle: Stock Futures Rise After Solid Jobs Report
MARKETS

Stock Futures Get Lift From Overseas Data; Jobless Claims Rise

Stock Markets Grind Higher as Apple Gains on Watch Sales
STOCKS

Morning Briefing: 10 Things You Should Know

3 Basic Materials Stocks Driving The Sector Higher
MARKETS

Trade-Ideas: Onyx Pharmaceuticals (ONXX) Is Today's Post-Market Leader Stock

Insurance M&A Seen Heating Up, Led By AIG, Ace and Markel
MERGERS AND ACQUISITIONS

The Deal: Onyx Trials Cloud Amgen Deal

Dating Sites: Best, Worst & Weirdest
OPTIONS

Confidence in ONXX/AMGN Deal